| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8605085 | The Journal of Pain | 2018 | 33 Pages |
Abstract
This article presents the results from an examination of tapentadol API across the Researched Abuse, Diversion and Addiction-Related Surveillance System: a broad and carefully designed postmarketing mosaic. Data to date from Poison Center, Drug Diversion, and Treatment Centers combined suggest a low, but present public health burden related to tapentadol.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Suzanne K. Vosburg, S. Geoffrey Severtson, Richard C. Dart, Theodore J. Cicero, Steven P. Kurtz, Mark W. Parrino, Jody L. Green,